Whether GJB2 or CCR5, attempting to edit these or other genes in human embryos for research purposes might be OK, permissions provided. But attempting to transfer these edited embryos into women is not. It was irresponsible in Nov 2018 and it is still now.
https://t.co/KNJm3b4NJn
His email & statements make it seem like he's more focused on doing some high-profile heritable human CRISPR (it almost doesn't seem to matter what gene & for what purpose/disease...he's bouncing around a lot on that) than actually realistically trying to help human health.
This morning I published my first non-scientific publication and I named it after the first season of our show!
46 Chromosomes and a Mule: Falsely Romanticizing Our Complex Genetic Identities for Profit https://t.co/ULwym0sOLu via @TheRoot
Read and share the knowledge!
Stanford clears 3 faculty members of ‘CRISPR babies’ involvement @sxbegle https://t.co/Rt8hOZNsJw Stanford got this right. Their researchers should have done more to alert community, but not necessarily so easy to do that #CRISPR
KOLs keep saying germline editing is a red line not to be crossed. I asked families affected by devastating inherited diseases how they feel about that: https://t.co/Hk1Ur8oz61
To investigate whether and how #CRISPR-Cas9 on-target and off-target activities are affected by chromatin in #eukaryotic cells, researchers at @SNUnow developed DIG-seq: an off-target profiling method using #chromatin DNA:
https://t.co/erNo9hrysL
@carlzimmer@antonioregalado@ZacharyBrennan@DrMJoyner @NIHDirector @RogerPielkeJr@matthewherper@sxbegle The FDA ban does NOT apply to in vitro work. The embryo isn’t the subject receiving the drug, it’s the drug and the woman is the “patient” to whom an unapproved new drug is being distributed. Research funding ban (Dickey/Wicker)applies to both with possible therapeutic exception
Chinese authorities have eventually reacted against Dr. He Jiankui —> Dr. He appeared to have “blatantly violated China’s relevant laws and regulations” and broken “the bottom line of morality and ethics that the academic community adheres to” via @nytimes https://t.co/9qdZ8IWPvl
BREAKING: Any more babies out there? Big question at end of #geneeditsummit in HK
NEW==> Jiankui He registered a *second* study on PCSK9 (low heart disease risk)
Says only involves embryo (no transfer).but who knows.
H/t @erikwestin for inspiration
https://t.co/4gG5dE1kss
I am a big @SGottliebFDA fan and think he is doing a great job @US_FDA(easily the Trump admin all-star)but I do take issue with some of what he told @BioCentury about the China #GeneEditing debacle. My take on our blog https://t.co/AkVcDyab2H maybe he was taken out of context
Fantastic speaker line-up at the Law, Genomic Medicine, & Health Equity conference in Nashville, TN this morning! I'll be live Tweeting key points from each of them throughout the day. #GenomicEquity